TYP Vision Formula
Natural health product licensed in Canada
- Other names
- Bestwell Vision Formula
- Licence holder
- TYP Pharmaceutical Ltd.
- NPN or DIN-HM
- 80063866
- Status
- Active licence
- Licence date
- 9 September 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-carotene-3,3'-diol totalement trans- Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 2.5 mg | Not calculated |
| Bêta-carotene-3,3'-diol totalement trans- Source : Zeaxanthin | 2.5 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 20 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Lutéine(USP) | 20 mg | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 2 mg | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 2 mg | Not calculated |
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one Source : Bioflavonoïdes d'agrumes | 50 mg | Not calculated |
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one Source : Citrus limon - Fruit | 50 mg | Not calculated |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extraction ratio : 10:1 Dry plant equivalent : 1,800 mg | 180 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Carbohydrate gum, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to improve macular pigment optical density. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration. Helps to reduce the risk of developing cataracts.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80063866
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.